In this 10-part series, we profile doctors who are working passionately to combat racism, change the system and improve patient care for racialized communities.
But when Marcia's condition deteriorated and she needed palliative care about a year ago, Marcaccio reached out for help from Ontario's home care system.
The regulatory filings include clinical data from a trial of 30,000 participants in the U.S. and Mexico, which found 100% protection against moderate and severe disease and 90.4% efficacy overall, Novavax said.
Non-immunogenic cancers have best outcomes—according to findings at the Anesthesiology 2021 annual meeting of a large retrospective study comparing 90-day survival.
